|
G |
Ace |
angiotensin I converting enzyme |
decreases expression |
EXP |
pirfenidone results in decreased expression of ACE protein |
CTD |
PMID:28091615 |
|
NCBI chr10:90,910,316...90,930,437
Ensembl chr10:90,910,316...90,931,131
|
|
G |
Ace2 |
angiotensin converting enzyme 2 |
increases expression |
EXP |
pirfenidone results in increased expression of ACE2 protein |
CTD |
PMID:28091615 |
|
NCBI chr X:30,293,597...30,340,961
Ensembl chr X:30,293,589...30,340,977
|
|
G |
Acta2 |
actin alpha 2, smooth muscle |
decreases expression multiple interactions |
ISO EXP |
pirfenidone results in decreased expression of ACTA2 mRNA; pirfenidone results in decreased expression of ACTA2 protein pirfenidone inhibits the reaction [Paraquat results in increased expression of ACTA2 mRNA] pirfenidone inhibits the reaction [Adenine results in increased expression of ACTA2 mRNA] |
CTD |
PMID:24706986 PMID:28091615 PMID:28866419 PMID:29273418 |
|
NCBI chr 1:231,746,527...231,759,307
Ensembl chr 1:231,746,548...231,759,554
|
|
G |
Agtr1a |
angiotensin II receptor, type 1a |
decreases expression |
EXP |
pirfenidone results in decreased expression of AGTR1 protein |
CTD |
PMID:28091615 |
|
NCBI chr17:34,173,446...34,226,892
Ensembl chr17:34,174,429...34,226,946
|
|
G |
Birc5 |
baculoviral IAP repeat-containing 5 |
decreases expression |
ISO |
pirfenidone results in decreased expression of BIRC5 mRNA |
CTD |
PMID:30481203 |
|
NCBI chr10:103,072,530...103,081,382
Ensembl chr10:103,073,408...103,081,380
|
|
G |
Cat |
catalase |
multiple interactions |
ISO EXP |
pirfenidone inhibits the reaction [Paraquat results in increased activity of CAT protein] [Prednisolone co-treated with pirfenidone] inhibits the reaction [Paraquat results in decreased activity of CAT protein]; pirfenidone inhibits the reaction [Paraquat results in decreased activity of CAT protein] |
CTD |
PMID:28696894 PMID:28921394 PMID:29273418 |
|
NCBI chr 3:89,842,393...89,874,577
Ensembl chr 3:89,842,399...89,874,478
|
|
G |
Ccn2 |
cellular communication network factor 2 |
multiple interactions |
ISO |
pirfenidone inhibits the reaction [Bleomycin results in increased expression of CCN2 protein] |
CTD |
PMID:35654123 |
|
NCBI chr 1:20,802,199...20,805,315
Ensembl chr 1:20,802,199...20,805,734
|
|
G |
Cdh1 |
cadherin 1 |
multiple interactions |
ISO EXP |
pirfenidone inhibits the reaction [Bleomycin results in decreased expression of CDH1 protein] pirfenidone inhibits the reaction [Adenine results in decreased expression of CDH1 protein] |
CTD |
PMID:28866419 PMID:35654123 |
|
NCBI chr19:34,492,371...34,561,775
Ensembl chr19:34,492,371...34,561,775
|
|
G |
Cdh2 |
cadherin 2 |
multiple interactions |
ISO |
pirfenidone inhibits the reaction [Bleomycin results in increased expression of CDH2 protein] |
CTD |
PMID:35654123 |
|
NCBI chr18:7,776,704...7,990,934
Ensembl chr18:7,776,704...7,990,167
|
|
G |
Col1a1 |
collagen type I alpha 1 chain |
multiple interactions decreases expression |
EXP ISO |
pirfenidone inhibits the reaction [Dimethylnitrosamine results in increased expression of COL1A1 mRNA] pirfenidone results in decreased expression of COL1A1 mRNA pirfenidone inhibits the reaction [Paraquat results in increased expression of COL1A1 mRNA] |
CTD |
PMID:15571005 PMID:27235791 PMID:29273418 |
|
NCBI chr10:79,883,622...79,900,625
Ensembl chr10:79,883,622...79,900,624
|
|
G |
Col4a1 |
collagen type IV alpha 1 chain |
multiple interactions |
ISO |
pirfenidone inhibits the reaction [Paraquat results in increased expression of COL4A1 mRNA] |
CTD |
PMID:29273418 |
|
NCBI chr16:78,183,533...78,294,412
Ensembl chr16:78,183,533...78,294,412
|
|
G |
Ctnnb1 |
catenin beta 1 |
multiple interactions |
EXP |
pirfenidone inhibits the reaction [Adenine results in increased expression of CTNNB1 protein] |
CTD |
PMID:28866419 |
|
NCBI chr 8:120,640,008...120,667,110
Ensembl chr 8:120,639,995...120,667,111
|
|
G |
Egfr |
epidermal growth factor receptor |
multiple interactions |
ISO |
[pirfenidone inhibits the reaction [EGFR protein binds to MAPK12 protein]] which results in decreased phosphorylation of PTPN3 protein; [pirfenidone inhibits the reaction [EGFR protein binds to MAPK12 protein]] which results in increased phosphorylation of EGFR protein; lapatinib promotes the reaction [pirfenidone inhibits the reaction [EGFR protein binds to MAPK12 protein]]; lapatinib promotes the reaction [pirfenidone inhibits the reaction [EGFR protein binds to PTPN3 protein]]; pirfenidone inhibits the reaction [EGFR protein binds to MAPK12 protein]; pirfenidone inhibits the reaction [EGFR protein binds to PTPN3 protein]; pirfenidone promotes the reaction [lapatinib inhibits the reaction [EGFR protein binds to MAPK12 protein]]; pirfenidone promotes the reaction [lapatinib inhibits the reaction [EGFR protein binds to PTPN3 protein]] |
CTD |
PMID:28739874 |
|
NCBI chr14:91,176,979...91,349,722
Ensembl chr14:91,177,067...91,344,382
|
|
G |
Esr1 |
estrogen receptor 1 |
multiple interactions |
ISO |
[pirfenidone inhibits the reaction [MAPK12 protein results in increased phosphorylation of ESR1 protein]] which results in decreased susceptibility to Tamoxifen; pirfenidone inhibits the reaction [MAPK12 protein results in increased phosphorylation of ESR1 protein] |
CTD |
PMID:22399296 |
|
NCBI chr 1:41,106,335...41,499,104
Ensembl chr 1:41,210,475...41,495,002
|
|
G |
Fn1 |
fibronectin 1 |
multiple interactions |
ISO EXP |
pirfenidone inhibits the reaction [Bleomycin results in increased expression of FN1 protein] pirfenidone inhibits the reaction [Adenine results in increased expression of FN1 protein] |
CTD |
PMID:28866419 PMID:35654123 |
|
NCBI chr 9:73,196,044...73,264,695
Ensembl chr 9:73,196,044...73,264,678
|
|
G |
Gpt |
glutamic--pyruvic transaminase |
multiple interactions |
ISO |
pirfenidone inhibits the reaction [Acetaminophen results in increased expression of GPT protein] |
CTD |
PMID:34890640 |
|
NCBI chr 7:108,416,646...108,419,495
Ensembl chr 7:108,416,642...108,419,494
|
|
G |
Gpx1 |
glutathione peroxidase 1 |
multiple interactions |
ISO |
pirfenidone inhibits the reaction [Paraquat results in decreased expression of GPX1 mRNA] |
CTD |
PMID:29273418 |
|
NCBI chr 8:109,026,905...109,028,031
Ensembl chr 8:109,026,905...109,028,024
|
|
G |
Hdac9 |
histone deacetylase 9 |
decreases expression |
ISO |
pirfenidone results in decreased expression of HDAC9 mRNA |
CTD |
PMID:30481203 |
|
NCBI chr 6:50,762,074...51,624,311
Ensembl chr 6:50,763,590...51,625,333
|
|
G |
Hif1a |
hypoxia inducible factor 1 subunit alpha |
multiple interactions |
ISO |
pirfenidone inhibits the reaction [Acetaminophen results in increased expression of HIF1A mRNA] |
CTD |
PMID:34890640 |
|
NCBI chr 6:92,624,059...92,669,262
Ensembl chr 6:92,624,390...92,669,261
|
|
G |
Hmox1 |
heme oxygenase 1 |
multiple interactions |
ISO |
pirfenidone inhibits the reaction [Acetaminophen results in increased expression of HMOX1 mRNA] |
CTD |
PMID:34890640 |
|
NCBI chr19:13,466,287...13,474,082
Ensembl chr19:13,467,244...13,474,079
|
|
G |
Jun |
Jun proto-oncogene, AP-1 transcription factor subunit |
multiple interactions |
ISO |
[pirfenidone inhibits the reaction [MAPK12 protein results in increased expression of JUN protein]] which results in decreased susceptibility to Tamoxifen; pirfenidone inhibits the reaction [MAPK12 protein results in increased expression of JUN protein] |
CTD |
PMID:22399296 |
|
NCBI chr 5:109,894,175...109,897,268
Ensembl chr 5:109,893,145...109,897,656
|
|
G |
Mapk12 |
mitogen-activated protein kinase 12 |
multiple interactions |
ISO |
[pirfenidone inhibits the reaction [EGFR protein binds to MAPK12 protein]] which results in decreased phosphorylation of PTPN3 protein; [pirfenidone inhibits the reaction [EGFR protein binds to MAPK12 protein]] which results in increased phosphorylation of EGFR protein; [pirfenidone inhibits the reaction [MAPK12 protein results in increased expression of JUN protein]] which results in decreased susceptibility to Tamoxifen; [pirfenidone inhibits the reaction [MAPK12 protein results in increased phosphorylation of ESR1 protein]] which results in decreased susceptibility to Tamoxifen; lapatinib promotes the reaction [pirfenidone inhibits the reaction [EGFR protein binds to MAPK12 protein]]; pirfenidone inhibits the reaction [EGFR protein binds to MAPK12 protein]; pirfenidone inhibits the reaction [MAPK12 protein results in increased expression of JUN protein]; pirfenidone inhibits the reaction [MAPK12 protein results in increased phosphorylation of ESR1 protein]; pirfenidone promotes the reaction [lapatinib inhibits the reaction [EGFR protein binds to MAPK12 protein]] |
CTD |
PMID:22399296 PMID:28739874 |
|
NCBI chr 7:120,206,005...120,216,711
Ensembl chr 7:120,206,271...120,216,664
|
|
G |
Mapk14 |
mitogen activated protein kinase 14 |
decreases expression |
EXP |
pirfenidone results in decreased expression of MAPK14 protein |
CTD |
PMID:28091615 |
|
NCBI chr20:6,749,646...6,810,590
Ensembl chr20:6,749,670...6,810,589
|
|
G |
Mapk8 |
mitogen-activated protein kinase 8 |
multiple interactions |
ISO |
pirfenidone inhibits the reaction [Acetaminophen results in increased phosphorylation of MAPK8 protein] |
CTD |
PMID:34890640 |
|
NCBI chr16:8,638,897...8,721,960
Ensembl chr16:8,638,924...8,721,981
|
|
G |
Mmp2 |
matrix metallopeptidase 2 |
multiple interactions |
EXP |
pirfenidone inhibits the reaction [Dimethylnitrosamine results in increased expression of MMP2 mRNA]; pirfenidone inhibits the reaction [Paraquat results in increased expression of MMP2 mRNA]; pirfenidone promotes the reaction [Prednisolone inhibits the reaction [Paraquat results in increased expression of MMP2 mRNA]] |
CTD |
PMID:15571005 PMID:28696894 PMID:28921394 |
|
NCBI chr19:14,154,657...14,182,870
Ensembl chr19:14,154,657...14,182,870
|
|
G |
Nos2 |
nitric oxide synthase 2 |
multiple interactions |
ISO |
pirfenidone inhibits the reaction [Paraquat results in increased expression of NOS2 mRNA] |
CTD |
PMID:29273418 |
|
NCBI chr10:63,815,308...63,851,208
Ensembl chr10:63,815,308...63,851,210
|
|
G |
Nox1 |
NADPH oxidase 1 |
multiple interactions |
ISO |
pirfenidone inhibits the reaction [Paraquat results in increased expression of NOX1 mRNA] |
CTD |
PMID:29273418 |
|
NCBI chr X:97,279,058...97,332,291
Ensembl chr X:97,279,056...97,302,236
|
|
G |
Nox4 |
NADPH oxidase 4 |
multiple interactions |
ISO |
pirfenidone inhibits the reaction [Paraquat results in increased expression of NOX4 mRNA] |
CTD |
PMID:29273418 |
|
NCBI chr 1:140,900,886...141,078,844
Ensembl chr 1:140,901,097...141,077,406
|
|
G |
Nr1h3 |
nuclear receptor subfamily 1, group H, member 3 |
increases expression |
EXP |
pirfenidone results in increased expression of NR1H3 protein |
CTD |
PMID:28091615 |
|
NCBI chr 3:77,158,808...77,168,907
Ensembl chr 3:77,158,808...77,168,722
|
|
G |
Ogg1 |
8-oxoguanine DNA glycosylase |
multiple interactions |
ISO |
pirfenidone inhibits the reaction [Bleomycin results in increased expression of OGG1 protein] |
CTD |
PMID:35654123 |
|
NCBI chr 4:146,474,701...146,481,959
Ensembl chr 4:146,474,750...146,484,766
|
|
G |
Pparg |
peroxisome proliferator-activated receptor gamma |
multiple interactions |
EXP |
pirfenidone inhibits the reaction [Adenine results in decreased expression of PPARG mRNA] |
CTD |
PMID:28866419 |
|
NCBI chr 4:148,423,102...148,548,471
Ensembl chr 4:148,423,194...148,548,468
|
|
G |
Ptpn3 |
protein tyrosine phosphatase, non-receptor type 3 |
multiple interactions |
ISO |
[pirfenidone inhibits the reaction [EGFR protein binds to MAPK12 protein]] which results in decreased phosphorylation of PTPN3 protein; lapatinib promotes the reaction [pirfenidone inhibits the reaction [EGFR protein binds to PTPN3 protein]]; pirfenidone inhibits the reaction [EGFR protein binds to PTPN3 protein]; pirfenidone promotes the reaction [lapatinib inhibits the reaction [EGFR protein binds to PTPN3 protein]] |
CTD |
PMID:28739874 |
|
NCBI chr 5:71,908,520...72,027,323
Ensembl chr 5:71,911,135...72,065,443
|
|
G |
Rela |
RELA proto-oncogene, NF-kB subunit |
multiple interactions |
EXP |
pirfenidone inhibits the reaction [Adenine results in increased expression of RELA mRNA] |
CTD |
PMID:28866419 |
|
NCBI chr 1:202,925,001...202,935,484
Ensembl chr 1:202,924,945...202,935,484
|
|
G |
Serpine1 |
serpin family E member 1 |
multiple interactions |
EXP ISO |
pirfenidone inhibits the reaction [Carbon Tetrachloride results in increased expression of SERPINE1 mRNA] pirfenidone inhibits the reaction [Acetaminophen results in increased expression of SERPINE1 mRNA] |
CTD |
PMID:12445421 PMID:34890640 |
|
NCBI chr12:19,601,272...19,611,657
Ensembl chr12:19,601,272...19,611,657
|
|
G |
Smad7 |
SMAD family member 7 |
multiple interactions |
EXP |
pirfenidone inhibits the reaction [Carbon Tetrachloride results in increased expression of SMAD7 mRNA] |
CTD |
PMID:12445421 |
|
NCBI chr18:68,988,429...69,016,774
Ensembl chr18:68,988,429...69,016,765
|
|
G |
Spp1 |
secreted phosphoprotein 1 |
multiple interactions |
EXP |
pirfenidone inhibits the reaction [Adenine results in increased expression of SPP1 mRNA] |
CTD |
PMID:28866419 |
|
NCBI chr14:5,308,885...5,315,120
Ensembl chr14:5,308,885...5,315,162
|
|
G |
Tgfb1 |
transforming growth factor, beta 1 |
multiple interactions |
ISO EXP |
pirfenidone inhibits the reaction [Paraquat results in increased expression of TGFB1 mRNA]; pirfenidone inhibits the reaction [Paraquat results in increased expression of TGFB1 protein] pirfenidone inhibits the reaction [Adenine results in increased expression of TGFB1 mRNA]; pirfenidone inhibits the reaction [Carbon Tetrachloride results in increased expression of TGFB1 mRNA]; pirfenidone inhibits the reaction [Dimethylnitrosamine results in increased expression of TGFB1 mRNA]; pirfenidone inhibits the reaction [Paraquat results in increased expression of TGFB1 mRNA]; pirfenidone promotes the reaction [Prednisolone inhibits the reaction [Paraquat results in increased expression of TGFB1 mRNA]] pirfenidone inhibits the reaction [Busulfan results in increased expression of TGFB1 mRNA] |
CTD |
PMID:12445421 PMID:15571005 PMID:21619834 PMID:28696894 PMID:28866419 PMID:28921394 PMID:29273418 PMID:37597760 More...
|
|
NCBI chr 1:81,196,532...81,212,848
Ensembl chr 1:81,196,532...81,212,847
|
|
G |
Timp1 |
TIMP metallopeptidase inhibitor 1 |
multiple interactions |
EXP |
pirfenidone inhibits the reaction [Carbon Tetrachloride results in increased expression of TIMP1 mRNA]; pirfenidone inhibits the reaction [Dimethylnitrosamine results in increased expression of TIMP1 mRNA]; pirfenidone inhibits the reaction [Paraquat results in increased expression of TIMP1 mRNA]; pirfenidone promotes the reaction [Prednisolone inhibits the reaction [Paraquat results in increased expression of TIMP1 mRNA]]; pirfenidone promotes the reaction [Tacrolimus results in decreased expression of TIMP1 mRNA] |
CTD |
PMID:12445421 PMID:15571005 PMID:15854665 PMID:28696894 PMID:28921394 |
|
NCBI chr X:1,212,969...1,217,714
Ensembl chr X:1,212,972...1,217,664
|
|
G |
Tnf |
tumor necrosis factor |
multiple interactions |
EXP |
[pirfenidone co-treated with Prednisolone] inhibits the reaction [Paraquat results in increased expression of TNF mRNA]; pirfenidone inhibits the reaction [Adenine results in increased expression of TNF mRNA]; pirfenidone inhibits the reaction [Paraquat results in increased expression of TNF mRNA] |
CTD |
PMID:28696894 PMID:28866419 PMID:28921394 |
|
NCBI chr20:3,622,011...3,624,629
Ensembl chr20:3,622,011...3,624,629
|
|